CS
CARM

Credit Suisse’s Carisma Therapeutics CARM Stock Holding History

Credit Suisse’s Portfolio CARM Stock Details CARM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Hold
0
– -$1 – 3332
2022
Q4 		– Hold
0
– – – 3913
2022
Q3 		– Hold
0
– – – 4056
2022
Q2 		– Hold
0
– – – 3957
2020
Q1 		– Sell
-12,563
Closed -$261K – 4002
2019
Q4 		$261K Buy
+12,563
New +$289K ﹤0.01% 3881
2017
Q1 		– Sell
-743
Closed -$28K – 3821
2016
Q4 		$28K Buy
+743
New +$32.7K ﹤0.01% 4057
2015
Q3 		– Sell
-661
Closed -$37K – 4278
2015
Q2 		$37K Buy
+661
New +$93.3K ﹤0.01% 4479

Other funds holding CARM

TOTUOP
Trustees of The University of Pennsylvania Philaldelphia, Pennsylvania $297M AUM
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $155M AUM 129.82% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
DCM
Deuterium Capital Management Clearwater, Florida $86M AUM 87.31% 1-Year Est. Return
WIM
Wittenberg Investment Management Carlisle, Massachusetts $269M AUM 28.17% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return